Cardiac toxicity associated with bevacizumab (Avastin) in combination with CHOP chemotherapy for peripheral T cell lymphoma in ECOG 2404 trial

Ranjana H. Advani, Fangxin Hong, Sandra J. Horning, Brad S. Kahl, Judith Manola, Lode J. Swinnen, Thomas M. Habermann, Kristen Ganjoo

Research output: Contribution to journal › Letter › peer-review

23 Scopus citations

Fingerprint

Dive into the research topics of 'Cardiac toxicity associated with bevacizumab (Avastin) in combination with CHOP chemotherapy for peripheral T cell lymphoma in ECOG 2404 trial'. Together they form a unique fingerprint.